1367 results
-
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 6-9 November 2023 (new)
CHMP, Last updated: 10/11/2023 -
List item
News: Call for expression of interest for independent scientific experts to participate in the work of EMA’s Safety Committee (new)
PRAC, Last updated: 03/11/2023 -
List item
Methodology Working Party stakeholder interaction meeting
Online, 07/12/2023, Last updated: 31/10/2023 -
List item
News: EMA recommends approval of adapted Nuvaxovid COVID-19 vaccine targeting Omicron XBB.1.5
CHMP, Last updated: 31/10/2023 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 23-26 October 2023
PRAC, Last updated: 27/10/2023 -
List item
Product Lifecycle Management (PLM) Value Stream Deep-Dive Webinar (updated)
Online 14:00 - 16:00 Amsterdam time (CEST), 30/11/2023, Last updated: 27/11/2023 -
List item
News: New treatment option for heavily pre-treated multiple myeloma patients
CHMP, Last updated: 13/10/2023 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 9-12 October 2023
CHMP, Last updated: 13/10/2023 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 25-28 September 2023
PRAC, Last updated: 29/09/2023 -
List item
News: EMA recommends non-renewal of authorisation of multiple myeloma medicine Blenrep
CHMP, Last updated: 28/09/2023 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 11-14 September 2023
CHMP, Last updated: 15/09/2023 -
List item
News: EMA recommends non-renewal of authorisation of Duchenne muscular dystrophy medicine Translarna
CHMP, Last updated: 05/10/2023 -
List item
News: Spikevax: EMA recommends approval of adapted COVID-19 vaccine targeting Omicron XBB.1.5
CHMP, Last updated: 14/09/2023 -
List item
News: PRAC recommends new measures to avoid topiramate exposure in pregnancy
PRAC, Last updated: 01/09/2023 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 28-31 August 2023
PRAC, Last updated: 01/09/2023 -
List item
News: Comirnaty: EMA recommends approval of adapted COVID-19 vaccine targeting Omicron XBB.1.5
CHMP, Last updated: 30/08/2023 -
List item
Press release: EMA review of data on paternal exposure to valproate
PRAC, Last updated: 16/08/2023 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 17-20 July 2023
CHMP, Last updated: 21/07/2023 -
List item
News: First RSV vaccine to protect infants up to 6 months of age and older adults
CHMP, Last updated: 21/07/2023 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 3 - 6 July 2023
PRAC, Last updated: 07/07/2023 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 19-22 June 2023
CHMP, Last updated: 23/06/2023 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 5 - 8 June 2023
PRAC, Last updated: 09/06/2023 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 May 2023
CHMP, Last updated: 26/05/2023 -
List item
News: Revocation of authorisation for sickle cell disease medicine Adakveo
CHMP, Last updated: 26/05/2023 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 10 - 12 May 2023
PRAC, Last updated: 22/05/2023